Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1680062/000165495418011149/acmr_8k.htm
November 2023
October 2023
September 2023
September 2023
September 2023
August 2023
July 2023
July 2023
July 2023
June 2023
|
Three
Months Ended March 31,
|
|||
|
GAAP
|
Non-GAAP(1)
|
||
|
2018
|
2017
|
2018
|
2017
|
|
(dollars
in thousands)
|
|||
Revenue
|
$9,743
|
$5,660
|
$9,743
|
$5,660
|
Gross
margin(2)
|
52.6%
|
42.4%
|
52.7%
|
42.4%
|
Income (loss) from
operations(2)
|
$(1,904)
|
$(1,553)
|
$271
|
$(718)
|
Net loss
attributable to ACM Research,
Inc.(2)
|
$(2,780)
|
$(2,089)
|
$(605)
|
$(1,254)
|
Basic
EPS
|
$(0.18)
|
$(0.43)
|
$(0.04)
|
$(0.26)
|
Diluted
EPS
|
$(0.18)
|
$(0.43)
|
$(0.04)
|
$(0.26)
|
|
Phone Number
|
Toll-Free Number
|
United States
|
+1 (845) 675-0437
|
+1 (866) 519-4004
|
Hong Kong
|
+852 3018 6771
|
+852 800906601
|
Mainland China
|
+86 (800) 819 0121
|
|
|
+86 (400) 620 8038
|
|
Other International
|
+65 6713 5090
|
|
|
March 31
|
December 31,
|
|
2018
|
2017
|
|
(unaudited)
|
(audited)
|
|
(in thousands, except share and per share data)
|
|
Assets
|
|
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
15,186
|
17,681
|
Accounts
receivable, less allowance for doubtful accounts of $0 as of March
31, 2018 and $0 as of December 31, 2017(note 3)
|
27,793
|
26,762
|
Other
receivables
|
1,222
|
2,491
|
Inventory
(note 4)
|
19,865
|
15,388
|
Prepaid
expenses
|
2,383
|
546
|
Other
current assets
|
45
|
46
|
Total current assets
|
66,494
|
62,914
|
Property,
plant and equipment, net (note 5)
|
2,731
|
2,340
|
Intangible
assets, net
|
126
|
106
|
Deferred
tax assets (note 15)
|
1,345
|
1,294
|
Investment
in affiliates, equity method (note 10)
|
1,238
|
1,237
|
Total assets
|
71,934
|
67,891
|
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
Current
liabilities:
|
|
|
Short-term
borrowings (note 6)
|
10,376
|
5,095
|
Notes
payable
|
0
|
11
|
Warrant
liability (note 8)
|
0
|
3,079
|
Accounts
payable (including amounts due to a related party of $264 at March
31, 2018 and $1,925 at December 31, 2017 (note 10))
|
5,525
|
7,419
|
Advances
from customers
|
264
|
143
|
Income
taxes payable
|
44
|
44
|
Other
payables and accrued expenses (including amounts due to a
related-party of $ 2,247 as of March 31, 2018 and $2,118 as of
December 31, 2017(note 11) (note 7))
|
6,542
|
6,026
|
Total
current liabilities
|
22,751
|
21,817
|
Other
long-term liabilities (note 9)
|
6,181
|
6,217
|
Total liabilities
|
28,932
|
28,034
|
|
|
|
Commitments and contingencies (Note 17)
|
|
|
Common
stock – Class A, with par value $0.0001: 100,000,000 shares
authorized, 13,390,270 shares issued and outstanding as of March
31, 2018; 100,000,000 shares authorized, 12,935,546 shares issued
and outstanding as of December 31, 2017; (note 13)
|
1
|
1
|
Common
stock – Class B, with par value $0.0001: 7,303,533 shares
authorized and 2,409,738 shares issued and outstanding as of March
31, 2018 and 7,303,533 shares authorized and 2,409,738 shares
issued and outstanding as of December 31, 2017 (note
13)
|
-
|
-
|
Additional
paid in capital
|
54,914
|
49,695
|
Accumulated
deficit
|
(12,740)
|
(9,961)
|
Accumulated
other comprehensive loss
|
827
|
122
|
Total stockholders’ equity
|
43,002
|
39,857
|
Total liabilities and stockholders’ equity
|
$71,934
|
$67,891
|
|
Three Months ended March 31,
|
|
|
2018
|
2017
|
|
(unaudited)
|
(unaudited)
|
|
(in thousands, except share and per share data)
|
|
Revenue
|
$9,743
|
$5,660
|
Cost
of revenue
|
4,621
|
3,258
|
Gross profit
|
5,122
|
2,402
|
Operating
expenses:
|
|
|
Sales
and marketing
|
1,855
|
1,163
|
Research
and development
|
1,541
|
928
|
General
and administrative
|
3,630
|
1,864
|
Total operating expenses, net
|
7,026
|
3,955
|
Loss from operations
|
(1,904)
|
(1,553)
|
Interest
income
|
3
|
2
|
Interest
expense
|
(103)
|
(78)
|
Other
income (expense), net
|
(754)
|
(64)
|
Equity
income in net income of affiliates
|
1
|
|
Loss before income taxes
|
(2,758)
|
(1,693)
|
Income
tax (expense) benefit (note 16)
|
(22)
|
(781)
|
Net loss
|
(2,780)
|
(2,474)
|
Less:
Net loss attributable to non-controlling interests
|
|
(385)
|
Net loss attributable to ACM Research, Inc.
|
(2,780)
|
(2,089)
|
Comprehensive
loss:
|
|
|
Net
loss
|
(2,780)
|
(2,474)
|
Foreign
currency translation adjustment
|
705
|
44
|
Comprehensive loss
|
(2,075)
|
(2,430)
|
Less:
Comprehensive loss attributable to non-controlling
interests
|
|
(369)
|
Total comprehensive loss attributable to ACM Research, Inc.
(note 2)
|
$(2,075)
|
$(2,061)
|
Net
loss per common share (note 2):
|
|
|
Basic
|
$(0.18)
|
$(0.43)
|
Diluted
|
$(0.18)
|
$(0.43)
|
|
|
|
Weighted-average
common shares outstanding used in computing per share amounts (note
2):
|
|
|
Basic
|
15,383,086
|
4,817,745
|
Diluted
|
15,383,086
|
4,817,745
|
|
Three Months Ended March 31,
|
|||||
|
2018
|
2017
|
||||
|
Actual
|
|
Adjusted
|
Actual
|
|
Adjusted
|
|
(GAAP)
|
|
(Non-GAAP)
|
(GAAP)
|
|
(Non-GAAP)
|
|
(in thousands)
|
|||||
|
|
|
|
|
|
|
Revenue
|
$9,743
|
$-
|
$9,743
|
$5,660
|
$-
|
$5,660
|
Cost
of revenue
|
(4,621)
|
(8)
|
(4,613)
|
(3,258)
|
(5)
|
(3,253)
|
Gross
profit
|
5,122
|
(8)
|
5,130
|
2,402
|
(5)
|
2,407
|
Operating
expenses:
|
|
|
|
|
|
|
Sales
and marketing
|
(1,855)
|
(34)
|
(1,821)
|
(1,163)
|
(6)
|
(1,157)
|
Research
and development
|
(1,541)
|
(27)
|
(1,514)
|
(928)
|
(13)
|
(915)
|
General
and administrative
|
(3,630)
|
(2,106)
|
(1,524)
|
(1,864)
|
(811)
|
(1,053)
|
Income
(Loss) from operations
|
$(1,904)
|
$(2,175)
|
$271
|
$(1,553)
|
$(835)
|
$(718)
|
Net
loss attributable to ACM Research, Inc.
|
$(2,780)
|
$(2,175)
|
$(605)
|
$(2,089)
|
$(835)
|
$(1,254)
|
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1680062/000165495418011149/acmr_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acm Research, Inc..
Acm Research, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Acm Research, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ACMREvents:
CIK: 1680062
Form Type: 8-K Corporate News
Accession Number: 0001654954-18-011149
Submitted to the SEC: Mon Oct 15 2018 4:36:30 PM EST
Accepted by the SEC: Mon Oct 15 2018
Period: Tuesday, May 8, 2018
Industry: Special Industry Machinery